Massachusetts Life Sciences Center

R&D

Massachusetts Governor Maura Healey took shots at the Trump Administration as she announced $40M in life sciences tax incentives at BIO 2025.

News

Ipsen's IBAT inhibitor Bylvay has failed a trial in biliary atresia, a rare and serious liver disease that affects babies and has limited treatments.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.